Can I take Larrea Tridentata with Adagrasib?
Oral Larrea tridentata (chaparral) products with oral adagrasib. Product composition and dose in historical spontaneous reports are incompletely characterized.
Read the interaction guide →Find the available answers about adagrasib and supplements. Each guide explains its evidence and the forms it covers.
9 published guides. Coverage is limited to the combinations listed.
Oral Larrea tridentata (chaparral) products with oral adagrasib. Product composition and dose in historical spontaneous reports are incompletely characterized.
Read the interaction guide →Oral Rheum undulatum products with oral adagrasib. Do not substitute evidence for R. palmatum, R. officinale, their hybrids or unidentified medicinal rhubarb.
Read the interaction guide →Oral Hypericum perforatum products with oral adagrasib. Hyperforin content and repeated use affect enzyme induction; low-hyperforin products and teas are not assumed safe substitutes.
Read the interaction guide →Oral Camellia sinensis leaf extracts during oral adagrasib treatment. Concentrated extracts and their EGCG content are distinct from brewed tea, caffeine content and total leaf weight.
Read the interaction guide →Symphytum officinale oral products with oral adagrasib, distinguished from short-term skin use of specified low-pyrrolizidine-alkaloid root medicines. Historical common-name comfrey leaf cases do not establish exact species identity.
Read the interaction guide →Adequate magnesium intake and clinician-directed replacement during oral adagrasib therapy. Dietary intake, oral supplements and treatment of clinically significant electrolyte abnormalities are distinct decisions.
Read the interaction guide →Oral Hydrastis canadensis root products with oral adagrasib. Authenticated root extract in the clinical probe study is not equivalent to isolated berberine or every goldenseal product.
Read the interaction guide →Oral Senna alexandrina stimulant laxatives with oral adagrasib. The inspected monograph covers defined pod preparations; chronic misuse, bowel cleansing, leaf products and combinations are distinct exposures.
Read the interaction guide →Adequate potassium intake and clinician-directed replacement during oral adagrasib therapy. Dietary intake, oral supplements and treatment of clinically significant electrolyte abnormalities are distinct decisions.
Read the interaction guide →A supplement missing from this list has not been cleared for use with the medication. These pages do not assess every product, formulation, or combination.
Publication status, clinical review and change history are shown in each interaction guide.